Europe Next-Generation Sequencing market is estimated to reach US$12.95 billion by 2032 from its current value of US$ 4.58 billion, with a compound annual growth rate 12.24% in the 2024–2032 period. This expansion is as a result of improvement in the genomic studies, the growing adoption of personalized medicine, and increased incidence of genetic diseases. Read More: https://www.renub.com/europe-next-generation-sequencing-market-p.php #Europe_Next_Generation_Sequencing_Market #Europe_Next_Generation_Sequencing_Market_Trends #Europe_Next_Generation_Sequencing_Market_Size #Europe_Next_Generation_Sequencing_Market_Share